To:
`
`Subject:
`
`Sent:
`
`Sent As:
`
`Attachments:
`
`Sanofi (sdouglass@frosszelnick.com)
`
`U.S. TRADEMARK APPLICATION NO. 85396658 - SANOFI - SYN 1009112
`
`9/29/2011 9:06:22 PM
`
`ECOM101@USPTO.GOV
`
`Attachment - 1
`Attachment - 2
`Attachment - 3
`Attachment - 4
`Attachment - 5
`Attachment - 6
`Attachment - 7
`Attachment - 8
`Attachment - 9
`Attachment - 10
`Attachment - 11
`Attachment - 12
`Attachment - 13
`Attachment - 14
`Attachment - 15
`Attachment - 16
`Attachment - 17
`Attachment - 18
`Attachment - 19
`Attachment - 20
`
`UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO)
`OFFICE ACTION (OFFICIAL LETTER) ABOUT APPLICANT’S TRADEMARK APPLICATION
`
`(cid:160) (cid:160)(cid:160)(cid:160) APPLICATION SERIAL NO. 85396658
`(cid:160)(cid:160)(cid:160)(cid:160) MARK: SANOFI(cid:160)(cid:160)(cid:160)(cid:160)(cid:160) (cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`(cid:160) (cid:160)
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160) APPLICANT:(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`(cid:160) (cid:160)(cid:160)(cid:160)(cid:160)(cid:160) CORRESPONDENT’S REFERENCE/DOCKET NO :(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`(cid:160)(cid:160)(cid:160)
`SYN 1009112(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160) CORRESPONDENT E-MAIL ADDRESS:(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`
`SUSAN UPTON DOUGLASS(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`FROSS ZELNICK LEHRMAN & ZISSU, P.C.(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`NEW YORK, NY 10017-1822(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`
`866 UNITED NATIONS PLZ
`
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`
`(cid:160)(cid:160)(cid:160) CORRESPONDENT ADDRESS:
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`
`*85396658*
`
`CLICK HERE TO RESPOND TO THIS LETTER:
`http://www.uspto.gov/trademarks/teas/response_forms.jsp
`
`(cid:160) Sanofi
`
`sdouglass@frosszelnick.com
`
`PRIORITY ACTION
`
`STRICT DEADLINE TO RESPOND TO THIS LETTER
`TO AVOID ABANDONMENT OF APPLICANT’S TRADEMARK APPLICATION, THE USPTO MUST RECEIVE APPLICANT’S
`COMPLETE RESPONSE TO THIS LETTER WITHIN 6 MONTHS OF THE ISSUE/MAILING DATE BELOW.
`
`(cid:160)I
`
`SSUE/MAILING DATE: 9/29/2011
`
`(cid:160)
`

`

`(cid:160)I
`
`SSUES APPLICANT MUST ADDRESS:(cid:160) On September 26, 2011, the trademark examining attorney and SUSAN UPTON DOUGLASS
`discussed the issues below.(cid:160) Applicant must timely respond to these issues.(cid:160) See 15 U.S.C. §1062(b); 37 C.F.R. §2.62(a); TMEP §§708, 711.
`
`(cid:160)P
`
`RELIMINARY AMENDMENT
`
`(cid:160)T
`
`he Preliminary Amendment, which is a translation of the French Registration(cid:160) is acceptable and has been entered into the record.(cid:160)(cid:160)
`SECTION 2(d) REFUSAL – LIKELIHOOD OF CONFUSION
`
`Registration of the applied-for mark is refused because of a likelihood of confusion with the marks in U.S. Registration Nos. 2914483 and
`3114466.(cid:160) Trademark Act Section 2(d), 15 U.S.C. §1052(d); see TMEP §§1207.01 et seq.(cid:160) See the enclosed registrations.
`
`(cid:160)T
`
`rademark Act Section 2(d) bars registration of an applied-for mark that so resembles a registered mark that it is likely that a potential consumer
`would be confused or mistaken or deceived as to the source of the goods and/or services of the applicant and registrant.(cid:160) See 15 U.S.C. §1052(d).(cid:160)
`The court in In re E. I. du Pont de Nemours & Co., 476 F.2d 1357, 177 USPQ 563 (C.C.P.A. 1973) listed the principal factors to be considered
`when determining whether there is a likelihood of confusion under Section 2(d).(cid:160) See TMEP §1207.01.(cid:160) However, not all of the factors are
`necessarily relevant or of equal weight, and any one factor may be dominant in a given case, depending upon the evidence of record.(cid:160) In re
`Majestic Distilling Co., 315 F.3d 1311, 1315, 65 USPQ2d 1201, 1204 (Fed. Cir. 2003); see In re E. I. du Pont, 476 F.2d at 1361-62, 177 USPQ at
`567.
`
`(cid:160)I
`
`n this case, applicant seeks to register the mark SANOFI for use in connection with “non-medicated skin care preparations; cosmetics; skin
`soaps and skin cleansers,” “house mark for a full line of pharmaceuticals and healthcare preparations,” “computer software for database
`management in the field of pharmaceutical and medical developments; CD-ROMs featuring health care information; medical imaging
`software; software downloadable via the internet or mobile phone applications for monitoring and tracking blood glucose levels,” “blood
`glucose monitors, lancets and control solutions; insulin injectors sold empty; asthma inhalers for medical and therapeutic use sold empty;
`diagnostic apparatus for medical purposes; radiological apparatus for medical purposes, radiological screens for medical purposes; surgical
`and medical apparatus and instruments in the field of ophthalmology and eye care; artificial eyes; suture materials,” “printed matter, namely,
`newsletters, magazines, journals, periodicals, pamphlets, books and posters, all related to health matters,” “business development and
`marketing services in the field of health care; organizing sales promotions and consulting in the field of sales promotions for the
`pharmaceutical industry,” “educational services, namely, providing conferences, seminars and workshops in the field of health care and
`pharmaceutical developments; publishing magazines, books, guides and databases in the field of medicine and pharmaceuticals; on-line
`journals, namely, blogs in the field of health care,” “medical and scientific research, namely, conducting clinical trials; providing medical
`
`research and scientific research information in the field of pharmaceuticals,” and “providing medical information.” (cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`
`Registrant’s marks are SLEEP SOLUTIONS FROM SANOFI-SYNTHELABO and design for use in connection with “providing online
`information in the field of sleep disorders” (2914483); and SANOFI AVENTIS and design for use in connection with “chemicals for use in the
`manufacture of pharmaceuticals or cosmetics,” “non-medicated skin care preparations; body soaps; toothpaste,” “house mark for a full line of
`pharmaceuticals and pharmaceutical preparations,” “surgical and medical apparatus and instruments for use in the field of oncology and
`cardiology, namely, syringes for medical use and urethral catheters,” “electronic delivery of text, images and photographs; providing online chat
`rooms for transmission of messages among computer users in the field of pharmaceutical and medical developments,” “providing medical
`research assistance to medical researchers; rental of laboratory equipment; biological, pharmaceutical and medical research; medical and
`scientific research, namely, conducting clinical research; hosting of web sites of others on the Internet in the field of medical and pharmaceutical
`information” (3114466).
`
`(cid:160)A
`
`s discussed below, the following factors are the most relevant here:(cid:160) similarity of the marks, similarity of the goods and/or services, and
`similarity of trade channels of the goods and/or services.(cid:160) See In re Opus One, Inc., 60 USPQ2d 1812 (TTAB 2001); In re Dakin’s Miniatures
`Inc., 59 USPQ2d 1593 (TTAB 1999); In re Azteca Rest. Enters., Inc., 50 USPQ2d 1209 (TTAB 1999); TMEP §§1207.01 et seq.
`
`(cid:160)I
`
`n a likelihood of confusion determination, the marks are compared for similarities in their appearance, sound, meaning or connotation and
`commercial impression.(cid:160) In re E. I. du Pont de Nemours & Co., 476 F.2d 1357, 1361, 177 USPQ 563, 567 (C.C.P.A. 1973); TMEP §1207.01(b).(cid:160)
`Similarity in any one of these elements may be sufficient to find a likelihood of confusion.(cid:160) In re White Swan Ltd., 8 USPQ2d 1534, 1535 (TTAB
`1988); In re Lamson Oil Co., 6 USPQ2d 1041, 1043 (TTAB 1987); see TMEP §1207.01(b).
`
`(cid:160)H
`
`ere, the marks share the dominant and arbitrary term SANOFI resulting in marks that are confusingly similar in commercial impression.(cid:160) It is
`well established that the mere deletion of wording from a registered mark may not be sufficient to overcome a likelihood of confusion.(cid:160) See In re
`Mighty Leaf Tea, 601 F.3d 1342, 94 USPQ2d 1257 (Fed. Cir. 2010); In re Optica Int’l , 196 USPQ 775, 778 (TTAB 1977); TMEP
`§1207.01(b)(ii)-(iii).(cid:160) Applicant’s mark does not create a distinct commercial impression because it contains the same common wording as
`registrant’s mark, and there is no other wording to distinguish it from registrant’s mark.
`
`(cid:160)T
`
`he goods and/or services of the parties need not be identical or directly competitive to find a likelihood of confusion.(cid:160) See Safety-Kleen Corp. v.
`
`

`

`Dresser Indus., Inc., 518 F.2d 1399, 1404, 186 USPQ 476, 480 (C.C.P.A. 1975); TMEP §1207.01(a)(i).(cid:160) Rather, they need only be related in
`some manner, or the conditions surrounding their marketing are such that they would be encountered by the same purchasers under
`circumstances that would give rise to the mistaken belief that the goods and/or services come from a common source.(cid:160) In re Total Quality Group,
`Inc., 51 USPQ2d 1474, 1476 (TTAB 1999); TMEP §1207.01(a)(i); see, e.g., On-line Careline Inc. v. Am. Online Inc., 229 F.3d 1080, 1086-87,
`56 USPQ2d 1471, 1475-76 (Fed. Cir. 2000); In re Martin’s Famous Pastry Shoppe, Inc. , 748 F.2d 1565, 1566-68, 223 USPQ 1289, 1290 (Fed.
`Cir. 1984).
`
`(cid:160)H
`
`ere, the goods and services are highly related, identical in part, and travel in the same trade channels.
`
`Although applicant’s mark has been refused registration, applicant may respond to the refusal(s) by submitting evidence and arguments in
`support of registration.
`
`(cid:160)I
`
`f the marks in the cited registrations have been assigned to applicant, applicant can provide evidence of ownership of the marks by satisfying one
`of the following:
`
`(1)(cid:160) Record the assignment with the Office’s Assignment Services Branch (ownership transfer documents such as assignments can be
`filed online at http://etas.uspto.gov) and promptly notify the trademark examining attorney that the assignment has been duly recorded;
`
`(2)(cid:160) Submit copies of documents evidencing the chain of title; or
`
`(3)(cid:160) Submit the following statement, verified with an affidavit or signed declaration under 37 C.F.R. §2.20:(cid:160) “Applicant is the owner of
`
`U.S. Registration Nos. 2914483 and 3114466.” (cid:160)(cid:160)
`
`TMEP §812.01; see 15 U.S.C. §1060; 37 C.F.R. §§2.193(e)(1), 3.25, 3.73; TMEP §502.02(a).
`
`(cid:160)M
`
`erely recording a document with the Assignment Services Branch does not constitute a response to an Office action.(cid:160) TMEP §503.01(d).
`
`Applicant must respond to the requirement(s) set forth below.
`
`(cid:160)C
`
`HANGE OF NAME DOCUMENT MUST BE TRANSLATED -- THIS PARTIAL REFUSAL APPLIES TO CLASSES 9, 10, 16, 41, 42
`AND 44 ONLY
`
`(cid:160)U
`
`nder Section 44(e), an applicant must be the owner of the foreign application or registration on the filing date of the U.S. application.(cid:160) TMEP
`§1005; see 37 C.F.R. §2.34(a)(3); In re De Luxe, N.V., 990 F.2d 607, 26 USPQ2d 1475 (Fed. Cir. 1993); In re Tong Yang Cement Corp., 19
`USPQ2d 1689 (TTAB 1991).(cid:160) However, in this case, the foreign registration specifies an owner other than the U.S. applicant.(cid:160) Specifically, the
`U.S. application specifies the owner as Sanofi, while the foreign registration specifies the owner as Sanofi-Aventis.
`
`(cid:160)I
`
`f applicant can prove the foreign registration was assigned to applicant on or before the filing date of the U.S. application, the Section 44(e)
`basis can remain in the application.(cid:160) TMEP §1005.(cid:160) Applicant has submitted a certified copy or certification from the foreign trademark office
`that reflects applicant’s ownership of the foreign registration and the date of the assignment/change of name, or evidence that the foreign
`registration was assigned to applicant on or before the filing date of the U.S. application.(cid:160) See TMEP §§1005, 1006.(cid:160) However, is not written in
`English, therefore, applicant must also provide an English translation.(cid:160) The translation should be signed by the translator.(cid:160) See TMEP
`§1004.01(b).
`
`(cid:160)I
`
`f applicant did not own the foreign registration on or before the filing date of the U.S. application, applicant may respond by substituting the
`basis for registration from Section 44(e) to Section 1(a) or 1(b), if applicant can satisfy the requirements for the new basis.(cid:160) See 15 U.S.C.
`§§1051(a)-(b), 1126(e); TMEP §806.03.(cid:160) A foreign registration certificate is not required for a Section 1(a) or 1(b) basis.(cid:160) See 15 U.S.C.
`§1051(a)-(b); TMEP §806.01(a)-(b).
`
`(cid:160)F
`
`OREIGN REGISTRATION CERTIFICATE OF RENEWAL MUST BE TRANSLATED(cid:160) -- THIS PARTIAL REQUIREMENT
`APPLIES TO CLASSES 3 AND 5 ONLY
`
`Applicant has provided a certificate of renewal or other certification from the intellectual property office of the foreign country that shows that
`the foreign registration has been renewed and will be in force at the time the registration issues in the United States.(cid:160) 37 C.F.R. §2.34(a)(3)(iii);
`TMEP §1004.01(a).(cid:160) However, the certificate of renewal is not written in English, therefore, applicant must also provide an English translation.(cid:160)
`See 37 C.F.R. §2.34(a)(3)(iii); TMEP §1004.01(a)-(b).(cid:160) The translation should be signed by the translator.(cid:160) See TMEP §1004.01(b).
`
`(cid:160)H
`
`OUSE MARK REQUEST UNACCEPTABLE -- THIS PARTIAL REQUIREMENT APPLIES TO CLASS 5 ONLY
`
`(cid:160)A
`
`pplicant’s request for registration of a “house mark” is unacceptable because it does not include evidence of use of the mark as a house mark,
`i.e., on a wide range of goods.(cid:160) See TMEP §1402.03(b).(cid:160)
`
`(cid:160)
`(cid:160)
`(cid:160)
`(cid:160)
`(cid:160)
`(cid:160)
`

`

`(cid:160)T
`
`herefore, applicant must provide evidence that shows use of the mark as a house mark.(cid:160) Such evidence may consist of product catalogs or
`
`similar evidence showing broad use of the mark.(cid:160) TMEP §1402.03(b); see 37 C.F.R. §2.61(b).(cid:160)(cid:160)
`
`If applicant is unable to provide such evidence, applicant must amend the identification to delete “house mark for” and specify the common
`commercial or generic name for each item.(cid:160) See TMEP §§1402.01, 1402.03(b).
`
`(cid:160)I
`
`DENTIFICATION OF GOODS -- THIS PARTIAL REQUIREMENT APPLIES TO CLASS 5 ONLY
`
`(cid:160)T
`
`he following wording in the identification of goods in the U.S. application is unacceptable because it exceeds the scope of the goods in the
`foreign application or registration:(cid:160) “house mark for a full line of . . . healthcare preparations.” (cid:160) See 37 C.F.R. §2.32(a)(6).(cid:160) Applicant may
`change this wording to “full line of veterinary preparations and sanitary preparations for medical use,” if accurate. (cid:160) See TMEP §1402.01.
`
`(cid:160)T
`
`herefore, applicant must either:
`
`(1)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`
`(2)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`
`Amend the identification of goods and/or services in the U.S. application to correspond to the goods and/or services in the foreign
`application or registration, ensuring that all goods and/or services beyond the scope of the foreign application or registration are
`deleted from the U.S. application; or
`
`Delete the Trademark Act Section 44 basis for the goods and/or services beyond the scope of the foreign application or registration
`and substitute a basis under Section 1(a) or 1(b) for those goods and/or services.
`
`(cid:160)S
`
`ee 15 U.S.C. §§1051(a)-(b), 1126; 37 C.F.R. §§2.32(a)(6), 2.34(b), 2.35(b); Marmark Ltd. v. Nutrexpa S.A., 12 USPQ2d 1843, 1845 (TTAB
`1989); TMEP §§806.02, 806.03(h), 1402.01(b).
`
`(cid:160)A
`
`n applicant may assert more than one basis in an application, provided that the applicant satisfies all requirements for each basis claimed.(cid:160) 37
`C.F.R. §2.34(b)(1); TMEP §806.02(a).(cid:160) If applicant asserts different bases in the same application, applicant must clearly state that more than
`one basis is being claimed, and must separately list each basis, followed by the goods and/or services to which that basis applies.(cid:160) If some or all
`of the goods and/or services are covered by more than one basis, this must also be expressly stated.(cid:160) 37 C.F.R. §§2.34(b)(2), 2.35(b)(6).
`
`(cid:160)A
`
`lthough multi-basis applications are permitted, applicant may not assert both use in commerce under Section 1(a) and intent to use under
`Section 1(b) for the same goods or services.(cid:160) 37 C.F.R. §2.34(b)(1); TMEP §806.02(b).
`
`(cid:160)C
`
`LAIM OF OWNERSHIP OF REGISTRATIONS
`
`(cid:160)I
`
`f applicant is the owner of U.S. Registration Nos. 2914521, 3174254, 4011299 and others, then applicant must submit a claim of ownership.(cid:160) See
`37 C.F.R. §2.36; TMEP §812.(cid:160) The following standard format is suggested:
`
`Applicant is the owner of U.S. Registration Nos. 2914521, 3174254, 4011299 and others.
`
`(cid:160)I
`
`f applicant has questions regarding this Office action, please telephone or e-mail the assigned trademark examining attorney.(cid:160) All relevant e-
`mail communications will be placed in the official application record; however, an e-mail communication will not be accepted as a response to
`this Office action and will not extend the deadline for filing a proper response.(cid:160) See 37 C.F.R. §2.191; TMEP §§709.04-.05.(cid:160) Further, although
`the trademark examining attorney may provide additional explanation pertaining to the refusal(s) and/or requirement(s) in this Office action, the
`trademark examining attorney may not provide legal advice or statements about applicant’s rights. (cid:160) See TMEP §§705.02, 709.06.
`
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`
`/Barbara Rutland/
`Trademark Examining Attorney
`U.S. Patent & Trademark Office
`Law Office 101
`571-272-9311
`barbara.rutland@USPTO.gov
`
`(cid:160)T
`
`O RESPOND TO THIS LETTER: (cid:160) Go to http://www.uspto.gov/trademarks/teas/response_forms.jsp. (cid:160) Please wait 48-72 hours from the
`issue/mailing date before using TEAS, to allow for necessary system updates of the application.(cid:160) For technical assistance with online forms, e-
`mail TEAS@uspto.gov.(cid:160) For(cid:160)questions about the Office action itself, please contact the assigned trademark examining attorney.(cid:160)(cid:160) E-mail
`
`(cid:160)
`(cid:160)
`(cid:160)
`

`

`communications will not be accepted as responses to Office actions; therefore, do not respond to this Office action by e-mail.
`
`(cid:160)A
`
`ll informal e-mail communications relevant to this application will be placed in the official application record.
`
`(cid:160)W
`
`HO MUST SIGN THE RESPONSE:(cid:160) It must be personally signed by(cid:160)an individual applicant or(cid:160)someone with legal authority to bind an
`applicant (i.e., a corporate officer, a general partner, all joint applicants).(cid:160)(cid:160)If an applicant is represented by an attorney, the attorney must sign the
`response.
`
`(cid:160)P
`
`ERIODICALLY CHECK THE STATUS OF THE APPLICATION: (cid:160) To ensure that applicant does not miss crucial deadlines or official
`notices, check the status of the application every three to four months using Trademark Applications and Registrations Retrieval (TARR) at
`http://tarr.uspto.gov/. (cid:160) Please keep a copy of the complete TARR screen. (cid:160) If TARR shows no change for more than six months, call
`1-800-786-9199. (cid:160) For more information on checking status, see http://www.uspto.gov/trademarks/process/status/.
`
`(cid:160)T
`
`O UPDATE CORRESPONDENCE/E-MAIL ADDRESS:(cid:160) Use the TEAS form at http://www.uspto.gov/teas/eTEASpageE.htm.
`
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`

`

`Print: Sep 28, 2011
`
`T826-I-I-T2
`
`TYPED DRAWING
`
`Serial Number
`18264472
`
`Status
`REGISTERED
`
`Word Marl:
`SANOEI-SYNTHELABO
`
`Standard Character Mark
`No
`
`Registration NI.II"I'IhBf
`2941621
`
`Date Registered
`2005fO4fl9
`
`Type of Mark
`TRADEMARPC;
`
`sERvIcE MARK
`
`Register
`PRINCIPAL
`
`Mark Drawing Code
`El] TYPED DRAWING
`
`U"NI1Bf
`SANOFI SOCIETE ANONYME FRANCE 17-4, AVENUE DE FRANCE PARIS FRANCE 75013
`
`Gnndsfservices
`Class Status -- ACT VH.
`
`C 001.
`
`US
`
`O01 O05 O06 O10 O26 046.
`
`G & S:
`
`chemicals for use in the manufacture of pharmaceuticals or cosmetics.
`
`Gnndsiservlces
`Class Status —— ACTIVE.
`
`IC 003.
`
`Us
`
`O01 O04 O06 O50 O51 052.
`
`G & S:
`
`non—medicated skin care preparations; body soaps;
`
`toothpaste.
`
`Goodsisarvlcas
`Class Status —— ACTIVE.
`
`IC 005.
`
`US
`
`O06 O18 O44 O46 O51 052.
`
`G & 5:
`
`house mark for a full line of pharmaceuticals and pharmaceutical
`preparations.
`
`Goodsfservices
`G & S:
`O21 O23 O26 O36 038.
`US
`IC 009.
`Class Status —— ACTIVE.
`pre-recorded audio cassettes, video cassettes, and multi-media
`software recorded on CD-ROMS in the field of pharmaceutical and
`medical developments; computer software for database management
`field of pharmaceutical and medical developments.
`
`in the
`
`-1-
`
`

`

`Print: Sep 28, 2011
`
`T826-I-I-T2
`
`Goodsiservines
`G & S: surgical
`O26 O39 044.
`US
`IC 010.
`Class Status -- ACTIVE.
`and medical apparatus and instruments for use in the field of oncology
`and cardiology, namely, syringes for medical use and urethral
`cat i”1E t E 133 .
`
`Goodsiservices
`Class Status —— ACTIVE.
`
`IC 016.
`
`US
`
`O02 O05 O22 O23 029 O3? O38 050.
`
`journals, and books in the fields of
`G & S: newspapers, periodicals,
`pharmaceuticals and medical developments.
`
`Goodsfservioes
`Class Status -- ACTIVE.
`
`IC 038.
`
`US
`
`100 101 IO4.
`
`G & 3: electronic
`
`rooms
`images and photographs; providing online chat
`delivery of text,
`for transmission of messages among computer users in the field of
`pharmaceutical and medical developments.
`
`Goodsfservices
`G & 3:
`IOT.
`100 lOl
`US
`IC 041.
`Class Status -- ACTIVE.
`organization of seminars, working groups, study groups and congresses,
`in the medical field; medical and pharmaceutical training; publishing
`of periodicals,books, guides and data bases in the medical field.
`
`Goodniservioes
`G & S: providing
`100 lOl.
`US
`IC 042.
`Class Status -- ACTIVE.
`medical research assistance to medical researchers; rental of
`laboratory equipment; biological, pharmaceutical and medical research;
`medical and scientific research, namely, conducting clinical research;
`hosting of web sites of others on the internet in the field of medical
`and pharmaceutical
`information.
`
`Goodsfservices
`Class Status —— ACTIVE.
`
`:c 044.
`
`Us
`
`100 101.
`
`G & 5: medical
`
`evaluation services, name_y, functional assessment programs for
`patients receiving medical treatment for the purpose of assessing
`medical treatment effectiveness; providing medical and pharmaceutical
`information; providing a database of medical and pharmaceutical
`information.
`
`Foreign Country Name
`FRANCE
`
`Foreign Registration Number
`023189696
`
`Foreign Registration Date
`2002HlOHl8
`
`Foreign Expiration Date
`20l2!l0Hl8
`
`

`

`Print: Sep 28, 2011
`
`T826-I-I-T2
`
`Prinr Registratinn(5)
`2113500 ; 2129809;AI~ID OTHERS
`
`Filing Date
`gooaxoexlg
`
`Examining Attorney
`KING, LINDA
`
`Attorney of Record
`Susan Upton Douglass
`
`

`

`Print: Sep 28, 2011
`
`78277719
`
`DESIGN MARK
`
`Serial Number
`18271719
`
`Status
`REGISTERED
`
`Word Mark
`SANOFI
`
`Standard Character Mark
`No
`
`Registration NI.II"I'IhBf
`2914521
`
`Date Registered
`2004fl2f2S
`
`Type of Mark
`TRADEMARPC;
`
`sERvIcE MARK
`
`Register
`PRINCIPAL
`
`Mark Drawing Code
`[5] WORDS, LETTERS, ANDIOR NUMBERS IN STYLIZED FORM
`
`U"NI1Bf
`SANOFI SOCIETE ANONYME FRANCE 17-4, AVENUE DE FRANCE PARIS FRANCE 75013
`
`Gnndsfservices
`Class Status -- ACT VH.
`
`C 003.
`
`US
`
`O01 O04 O06 O50 O51 052.
`
`G & S:
`
`non—medicated skin care preparations: body soaps:
`
`toothpastes.
`
`Gnndsiservlces
`Class Status —— ACTIVE.
`
`IC 005.
`
`US
`
`O06 O18 O44 O46 O51 052.
`
`G & S:
`
`house mark for a full line of pharmaceuticals, pharmaceutical
`preparations and healthcare preparations.
`
`Goodsfservices
`G & S: Providing
`100 101.
`US
`IC 042.
`Class Status —— ACTIVE.
`medical research assistance to medical researchers; rental of
`laboratory equipment; biological, pharmaceutical and medical research;
`medical and scientific research, namely, conducting clinical trials;
`scientific research.
`
`Foreign country Name
`FRANCE
`
`

`

`Print: Sep 28, 2011
`
`78277719
`
`Foreign Registration Number
`96665339
`
`Foreign Registration Date
`l996Hl2Hll
`
`Foreign Expiration Date
`Zflflfiflzfll
`
`Prior Reglstratloms)
`2ll3500;2129809
`
`Filing Date
`2003fOTf23
`
`Examining Attorney
`KING, LINDA
`
`Attorney of Record
`Susan Upton Douglass
`
`

`

`

`

`Print: Sep 28, 2011
`
`T900?!-BB
`
`DESIGN MARK
`
`Serial Number
`19001488
`
`Status
`REGISTERED
`
`Word Marl:
`SANOFI -AVEINTI 8
`
`Standard Character Mark
`Yes
`
`Registration NI.II"I'IhBf
`3l?4254
`
`Date Registered
`2006fllf2l
`
`Type of Mark
`TRADEMARPC; SERVICE MARI-C
`
`Register
`PRINCIPAL
`
`Mark Drawing Code
`[4]
`STANDARD CHARACTER MARK
`
`CMNHBT
`SANOFI Scciété Ancnyme FRANCE 174, avenue de France, F-75013 PARIS
`FRANCE
`
`Goodslse-wines
`Class Status —— ACTIVE.
`
`IC 001.
`
`US
`
`001 O05 O06 O10 O26 046.
`
`G & s:
`
`chemicals for use in the manufacture of pharmaceuticals or cosmetics.
`
`Goodsfservices
`Class Status —— ACTIVE.
`
`IC 003.
`
`US
`
`O01 O04 O06 O50 O51 052.
`
`G & S:
`
`non—medicated skin care preparations; body soaps;
`
`toothpaste.
`
`Goodsfservices
`O06 O18 O44 O46 G51 052.
`US
`IC 005.
`Class Status —— ACTIVE.
`house mark for a full line of pharmaceuticals and pharmaceutical
`preparations.
`
`G & S:
`
`Goodsfservices
`Class Status -- ACTIVE.
`
`IC 009.
`
`US
`
`O21 O23 O26 O36 038.
`
`G & S:
`
`pre-recorded audio cassettes, video cassettes, and multi-media
`software recorded on CD—ROMs
`in the field of pharmaceutical and
`medical developments; computer software for database management
`
`in the
`
`-1-
`
`

`

`Print: Sep 28, 2011
`
`T900?!-BB
`
`field of pharmaceutical and medical developments.
`
`Goodslservices
`G & S: surgical
`O26 O39 044.
`US
`IC 010.
`Class Status —— ACTIVE.
`and medical apparatus and instruments for use in the field of oncology
`and cardiology, namely, syringes for medical use and urethral
`catheters.
`
`Goodsfservices
`Class Status -- ACTIVE.
`
`IC 016.
`
`US
`
`O02 O05 O22 O23 029 O3? O38 050.
`
`journals, and books in the fields of
`G & S: newspapers, periodicals,
`pharmaceuticals and medical developments.
`
`GDDHSISEHIICES
`Class Status —— ACT VH.
`
`C 038.
`
`US
`
`100 lOl
`
`IO4.
`
`G & S: electronic
`
`rooms
`images and photographs; providing online chat
`delivery of text,
`for transmission of messages among computer users in the field of
`pharmaceutical and medical developments.
`
`Goodsiservices
`G & S:
`IOT.
`100 lOl
`US
`IC 041.
`Class Status -- ACTIVE.
`organization of seminars, working groups, study groups and congresses,
`in the medical field; medical and pharmaceutical training; publishing
`of periodicals, books, guides and data bases in the medical field.
`
`Goodslsarvlcas
`G & S: providing
`100 lOl.
`US
`IC 042.
`Class Status —— ACTIVE.
`medical research assistance to medical researchers; rental of
`laboratory equipment; biological, pharmaceutical and medical research;
`medical and scientific research, namely, conducting clinical research;
`hosting of web sites of others on the Internet in the field of medical
`and pharmaceutical
`information.
`
`GOOHSISEWIEBE
`Class Status —— ACTIVE.
`
`IC 044.
`
`US
`
`100 lOl.
`
`G & S: medical
`
`evaluation services, namely, functional assessment programs for
`patients receiving medical treatment for the purpose of assessing
`medical treatment effectiveness; providing medical and pharmaceutical
`information; providing a database of medical and pharmaceutical
`information.
`
`Priority Data
`2oo4xo4x2a
`
`Prior Registratiun(s)
`2503413;29l452l;294l62l;AND OTHERS
`
`Filing Date
`2004flOf0l
`
`Examining Attnmey
`
`

`

`Print: Sep 28, 2011
`
`T900?!-BB
`
`LAVACHE , ROBERT
`
`Attorney of Record
`SUSAN LIPTON DOUGLASS
`
`

`

`

`

`Print: Sep 28, 2011
`
`85094116
`
`Issue: Oct 4, 2011
`
`DESIGN MARK
`
`Serial Number
`85094146
`
`Status
`REGISTERED
`
`Word Mark
`O SANOFI AVENTIS ONCOLOGY
`
`Standard Character Mark
`No
`
`Registration NI.II"I'IhBf
`40ll299
`
`Date Registered
`20llfO8fl6
`
`Type of Mark
`TRADEMARPC; SERVICE MARK
`
`Register
`PRINCIPAL
`
`Mark Drawing Code
`[3] DESIGN PLUS WORDS, LETTERS ANDJOR NUMBERS
`
`U'WI1Bf
`sanofi CORPORATION FRANCE :74, avenue de France 75013 Paris FRANCE
`
`Gnndsfservices
`Class Status -- ACT VH.
`
`C 005.
`
`US
`
`O06 O18 O44 O46 O51 052.
`
`G & S:
`
`pharmaceutical preparations for the diagnosis, prevention and
`treatment of cancer.
`
`Goodsfservices
`Class Status —— ACTIVE.
`
`IC 009.
`
`US
`
`O21 O23 O26 O36 038.
`
`G & S:
`
`in the field of oncology;
`computer software for database management
`audio and video recordings in the field of oncology.
`
`Goodsfservices
`G & S:
`O26 O39 044.
`US
`IC 010.
`Class Status -- ACTIVE.
`radiological apparatus for medical purposes, radiology screens for
`medical purposes.
`
`Goodsfserviues
`Class Status —— ACTIVE.
`
`IC O16.
`
`US
`
`OO2 OO5 O22 O23 029 O3? O38 050.
`
`G & S: printed materials, namely, newsletters, magazines,
`periodicals, pamphlets, books, and posters distributed in the field of
`
`-1-
`
`

`

`Print: Sep 28, 2011
`
`85094116
`
`Issue: Oct 4, 2011
`
`oncology.
`
`Goodsiservices
`G & S: promoting
`lO2.
`100 lOl
`US
`IC 035.
`Class Status —— ACTIVE.
`the exchange of information and resources within the scientific
`JZ‘ESEElI‘Ci"1 Elfld medical CO1T'lIf'iL11"1ltlES ‘CO E1Ci"1lEVE advances lI"1 ti”1E flElCi Of
`
`healthcare; organizing, promoting and conducting exhibitions for
`commercial or advertising purposes; consulting with hospitals or
`doctors on managing an oncology practice.
`
`Goodsiservioes
`Class Status —— ACTIVE.
`
`IC 041.
`
`US
`
`100 lOl
`
`IOT.
`
`G & 3: educational
`
`services for consumers and professionals in the field of oncology,
`namely, arranging and conducting classes, seminars, programs,
`conferences, courses and workshops in the fields of oncology and eye
`care, and instructional materials distributed therewith; conducting
`online educational exhibitions, displays and interactive exhibits in
`the field of oncology; providing on-line non-downloadable publications
`and audio—video materials in the field of oncology.
`
`Goodsiservioes
`G & S: biological,
`100 lOl.
`US
`EC 042.
`Class Status -- ACTIVE.
`pharmaceutical and medical research; medical and scientific research,
`namely, conducting clinical trials in the field of oncology;
`industrial analysis and research services: conception and development
`of software, data management software.
`
`Cs‘-oodsiservioes
`G & 8: providing
`100 lOl.
`US
`IC 044.
`Class Status —— ACTIVE.
`cancer screening services; providing information in the field of
`cancer prevention, screening, diagnosis and treatment; consultation
`concerning oncology, namely, awareness programs and disease management
`programs.
`
`Foreign Country Name
`FRANCE
`
`Foreign Registration Numb-or
`lOf3T599l9
`
`Foreign Registration Date
`2DlDfDBfll
`
`Foreign Expiration Date
`202OHO8Hll
`
`Prior Registratioms]
`25034l3:3lT4254;AND OTHERS
`
`Disclaimer Statement
`No CLAIM IS MADE To THE EXCLUSIVE RIGHT To USE "ONCOLOGY" APART mom
`
`4.
`
`

`

`Print: Sep 28, 2011
`
`85094116
`
`Issue: Oct 4, 2011
`
`THE MARK AS SHOWN.
`
`Description of Mark
`The mark consists of a stylized letter "0" formed by four curved,
`nearly—olosed oresoents nesting together in descending size. Below are
`the words "SANOFI AVENTIS ONCOLOGY".
`
`colors Claimed
`Color is not olaimed as a feature of the mark.
`
`Filing Date
`2010f07X27
`
`Examining Attomay
`NELSON, EDWARD H.
`
`Attorney of Record
`Susan Upton Douglass
`
`

`

`©
`
`sunori cnrentis
`
`nH:uLnnv
`
`

`

`Print: Sep 28, 2011
`
`79010818
`
`DESIGN MARK
`
`Serial Number
`19010818
`
`Status
`REGISTERED
`
`Word Marl:
`SANOFI AVENTIS
`
`Standard Character Mark
`No
`
`Registration NI.II"I'IhBf
`3114466
`
`Date Registered
`2006fO?f11
`
`Type of Mark
`TRADEMARPC;
`
`sERvIoE MARK
`
`Register
`PRINCIPAL
`
`Mark Drawing Code
`[3] DESIGN PLUS WORDS, LETTERS ANDJOR NUMBERS
`
`CMNHBT
`SANOFI—AVENTIS Société Anonyme FRANCE 174, avenue de France F-75013
`PARIS FRANCE
`
`Goodslse-wines
`Class Status —— ACTIVE.
`
`IC 001.
`
`US
`
`001 O05 O06 O10 O26 046.
`
`G & s:
`
`chemicals for use in the manufacture of pharmaceuticals or cosmetics.
`
`Goodsfservices
`Class Status —— ACTIVE.
`
`IC 003.
`
`US
`
`O01 O04 O06 O50 O51 052.
`
`G & S:
`
`non—medicated skin care preparations; body soaps;
`
`toothpaste.
`
`Goodsfservices
`O06 O18 O44 O46 G51 052.
`US
`IC 005.
`Class Status —— ACTIVE.
`house mark for a full line of pharmaceuticals and pharmaceutical
`preparations.
`
`G & S:
`
`Goodsfservices
`G & S: surgical
`O26 O39 044.
`US
`IC 010.
`Class Status -- ACTIVE.
`and medical apparatus and instruments for use in the field of oncology
`and cardiology, namely, syringes for medical use and urethral
`catheters.
`
`-1-
`
`

`

`Print: Sep